Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$58M |
| 2 |
Wells Fargo
WFC
|
+$39.8M |
| 3 |
Northrop Grumman
NOC
|
+$39.6M |
| 4 |
Pfizer
PFE
|
+$37.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$33.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$59.8M |
| 2 |
Cigna
CI
|
+$42M |
| 3 |
Altria Group
MO
|
+$28.5M |
| 4 |
Philip Morris
PM
|
+$28.3M |
| 5 |
Parker-Hannifin
PH
|
+$26.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Industrials | 18.96% |
| 3 | Consumer Discretionary | 15.28% |
| 4 | Healthcare | 13.64% |
| 5 | Consumer Staples | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NATI
651
DELISTED
National Instruments Corp
NATI
| $1.02M | 0.02% |
+23,094
| New | +$1.05M |
|
|
VG
652
DELISTED
Vonage Holdings Corporation
VG
| $1.02M | 0.02% |
101,788
-459,692
| -82% | -$4.41M |
|
653
Range Resources
RRC
$9.58B
| $1.02M | 0.01% |
+90,368
| New | +$980K |
|
654
DaVita
DVA
$11.1B
| $1.01M | 0.01% |
18,669
-111,878
| -86% | -$6.19M |
|
655
Kulicke & Soffa
KLIC
$4.41B
| $1M | 0.01% |
45,377
-46
| -0.1% | -$1.02K |
|
|
MDP
656
DELISTED
Meredith Corporation
MDP
| $1M | 0.01% |
18,095
+6,106
| +51% | +$339K |
|
657
Asbury Automotive
ABG
$3.82B
| $997K | 0.01% |
14,374
+1,709
| +13% | +$119K |
|
658
Children's Place
PLCE
$59.8M
| $990K | 0.01% |
10,181
-19,385
| -66% | -$1.77M |
|
659
Sempra
SRE
$55.1B
| $983K | 0.01% |
+15,620
| New | +$920K |
|
660
Netflix
NFLX
$335B
| $979K | 0.01% |
27,460
+18,620
| +211% | +$646K |
|
|
MRC
661
DELISTED
MRC Global
MRC
| $977K | 0.01% |
+55,884
| New | +$911K |
|
|
FOE
662
DELISTED
Ferro Corporation
FOE
| $977K | 0.01% |
+51,590
| New | +$910K |
|
663
Casey's General Stores
CASY
$31.5B
| $974K | 0.01% |
7,561
-22,402
| -75% | -$2.93M |
|
664
Badger Meter
BMI
$3.88B
| $969K | 0.01% |
+17,421
| New | +$968K |
|
665
Columbus McKinnon
CMCO
$518M
| $968K | 0.01% |
28,176
+6,832
| +32% | +$238K |
|
|
JCP
666
DELISTED
J.C. Penney Company, Inc.
JCP
| $964K | 0.01% |
+647,076
| New | +$911K |
|
667
Signet Jewelers
SIG
$3.24B
| $962K | 0.01% |
35,434
-25,667
| -42% | -$708K |
|
|
JBTM
668
JBT Marel
JBTM
$5.88B
| $962K | 0.01% |
+10,472
| New | +$884K |
|
669
Huron Consulting
HURN
$2.59B
| $960K | 0.01% |
20,330
+3,230
| +19% | +$159K |
|
670
CONMED
CNMD
$1.55B
| $953K | 0.01% |
11,460
-7,356
| -39% | -$534K |
|
|
ALXN
671
DELISTED
Alexion Pharmaceuticals
ALXN
| $943K | 0.01% |
6,975
-16,422
| -70% | -$2.04M |
|
|
SYNH
672
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $941K | 0.01% |
18,180
-30,439
| -63% | -$1.48M |
|
673
Kforce
KFRC
$1.03B
| $939K | 0.01% |
26,743
-12,759
| -32% | -$443K |
|
674
Trex
TREX
$4.78B
| $938K | 0.01% |
30,498
-195,182
| -86% | -$6.82M |
|
675
Angi Inc
ANGI
$198M
| $932K | 0.01% |
6,033
-2,962
| -33% | -$480K |
|
Similar funds
Joel Greenblatt's Q1 2019 Portfolio in Review
As of Q1 2019, Joel Greenblatt held 1,284 positions worth $6.83B, up 6.1% from $6.44B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $437M in Q1 2019, closing 124 positions and reducing 485 holdings. Its most notable exit was Cigna, an estimated $42M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Joel Greenblatt opened a new position in General Dynamics worth $58.2M.
- Joel Greenblatt's largest Q1 2019 buy was General Dynamics: 343,980 shares worth $58.2M.
- Joel Greenblatt added most to Wells Fargo in Q1 2019, an estimated $39.8M increase.
- Joel Greenblatt's biggest Q1 2019 reduction was RTX Corp, cutting an estimated $59.8M.
- Joel Greenblatt fully exited Cigna in Q1 2019, selling an estimated $42M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.83B portfolio in Q1 2019.
- Joel Greenblatt opened 319 new positions and closed 124 in Q1 2019.
- Joel Greenblatt's portfolio value rose 6.1% quarter-over-quarter to $6.83B.
Based on Gotham Asset Management's 13F filing for Q1 2019, filed 15 May 2019.